Some patients use a cycling strategy: achieving weight loss on standard GLP-1 doses, then switching to a maintenance microdose or taking scheduled breaks while reinforcing diet and exercise habits
Imaging studies using magnetic resonance imaging-proton density fat fraction (MRI-PDFF), a validated non-invasive method for quantifying hepatic steatosis, have shown significant reductions in liver fat content with GLP-1 therapy
Weight-loss speed can vary based on factors such as starting weight, dosage level, metabolic health, diet, physical activity, and how consistently the medication is taken
This is the raw peptide in its most stable form, waiting for reconstitution before it becomes anything usable
GLP-1s are tools, not solutions